129 related articles for article (PubMed ID: 36928309)
21. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye.
Serna-Ojeda JC; Nava-Castaneda A
Acta Ophthalmol; 2017 Mar; 95(2):e132-e137. PubMed ID: 27350144
[TBL] [Abstract][Full Text] [Related]
22. Application of botulinum toxin in Horner's muscle for the treatment of dry eye.
Diaz AL; Chaparro TA; Tello A; Coy H; Frederick GA; Parra MM
Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):617-620. PubMed ID: 30001848
[TBL] [Abstract][Full Text] [Related]
23. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
[TBL] [Abstract][Full Text] [Related]
24. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
[TBL] [Abstract][Full Text] [Related]
25. Lid wiper epitheliopathy in patients with blepharospasm and/or hemifacial spasm.
Romero-Caballero MD; Salmerón Ato MP; Palazón-Cabanes A; Caravaca-Alegría A
Arch Soc Esp Oftalmol (Engl Ed); 2022 Jul; 97(7):376-380. PubMed ID: 35292220
[TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin A Injection for the Treatment of Intractable Dry Eye Disease.
Choi EW; Yeom DJ; Jang SY
Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33800125
[No Abstract] [Full Text] [Related]
27. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
Li XH; Lin SC; Hu YF; Liu LY; Liu JB; Hong YC
Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
[TBL] [Abstract][Full Text] [Related]
28. THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM.
Gaćina K; Lešin M; Sarajčev D; Rotim N
Acta Clin Croat; 2022 Nov; 61(3):379-385. PubMed ID: 37492354
[TBL] [Abstract][Full Text] [Related]
29. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
[TBL] [Abstract][Full Text] [Related]
30. Tear osmolarity, dry eye syndrome, blepharospasm and botulinum neurotoxin.
Girard B; de Saint Sauveur G
J Fr Ophtalmol; 2021 Dec; 44(10):1553-1559. PubMed ID: 34756743
[TBL] [Abstract][Full Text] [Related]
31. Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm.
Zhou Y; Wang W; Lin Z; Lin T; Gong L
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3615-3623. PubMed ID: 37341835
[TBL] [Abstract][Full Text] [Related]
32. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
Price J; Farish S; Taylor H; O'Day J
Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
[TBL] [Abstract][Full Text] [Related]
33. Blinking Parameters Do Not Normalize After Botulinum Toxin Therapy in Blepharospasm and Hemifacial Spasm Patients.
Gameiro GR; Osaki MH; Yabumoto C; Osaki T; Garcia DM; Belfort R; Cruz AAV; Osaki TH
J Neuroophthalmol; 2023 Dec; 43(4):563-568. PubMed ID: 37307066
[TBL] [Abstract][Full Text] [Related]
34. [Dry eye and qualitative tear alteration in essential blepharospasm].
Girard B; Begnaud S
J Fr Ophtalmol; 2022 Mar; 45(3):288-297. PubMed ID: 35148903
[TBL] [Abstract][Full Text] [Related]
35. Impact of botulinum toxin injections on quality of life and self-esteem in patients with blepharospasm.
Tang M; Li W; Ji F; Li X; Zhang Y; Liu P
Psychol Health Med; 2019 Jun; 24(5):513-518. PubMed ID: 30463432
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
Winterhoff J; Laskawi R
HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
[TBL] [Abstract][Full Text] [Related]
37. Riolan's muscle: action and indications for botulinum toxin injection.
Mackie IA
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
[TBL] [Abstract][Full Text] [Related]
38. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
[TBL] [Abstract][Full Text] [Related]
39. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
[TBL] [Abstract][Full Text] [Related]
40. Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Nallasamy N; Campos M
Br J Ophthalmol; 2016 Jul; 100(7):963-970. PubMed ID: 26541432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
